[{"PropertyPlantAndEquipmentNet_0_Q2_USD":38371000.0,"Liabilities_0_Q2_USD":150656000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":900000.0,"DepreciationAndAmortization_2_Q2_USD":3667000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"LiabilitiesNoncurrent_0_Q2_USD":104561000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":23526000.0,"InterestPaidNet_2_Q2_USD":2943000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-4595000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-6191000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":29564000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":1865000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":30534000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-14502000.0,"AssetsCurrent_0_Q2_USD":694224000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-539000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":30300000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":17299000.0,"DerivativeGainLossOnDerivativeNet_2_Q2_USD":12279000.0,"ProceedsFromIssuanceOfLongTermDebt_2_Q2_USD":34603000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":23178000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":23178000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":3361343.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":3393724.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":911000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-6942000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":677330000.0,"OtherAssetsNoncurrent_0_Q2_USD":5760000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":10444000.0,"EarningsPerShareBasic_2_Q2_USD":7.82,"EarningsPerShareBasic_1_Q2_USD":8.68,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-1665000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":46678835.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":46929870.0,"PrepaidExpenseCurrent_0_Q2_USD":10861000.0,"OtherExpenses_2_Q2_USD":459000.0,"OtherExpenses_1_Q2_USD":226000.0,"AccountsReceivableNetCurrent_0_Q2_USD":2705000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":3471000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":3258000.0,"CommonStockValue_0_Q2_USD":2788000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_2_Q2_USD":19400000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":11209000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":6583000.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.01,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.008,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":65128000.0,"CostsAndExpenses_2_Q2_USD":118255000.0,"CostsAndExpenses_1_Q2_USD":73224000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":1334000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":357912000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":399468000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":343410000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":392526000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":519000.0,"CommonStockSharesIssued_0_Q2_shares":46050250.0,"Assets_0_Q2_USD":784264000.0,"ShareBasedCompensation_2_Q2_USD":12792000.0,"EarningsPerShareDiluted_2_Q2_USD":7.67,"EarningsPerShareDiluted_1_Q2_USD":8.51,"RestrictedCashNoncurrent_0_Q2_USD":2828000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":37300000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-14502000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-6942000.0,"Goodwill_0_Q2_USD":525000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":361383000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":402726000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":12792000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":7031000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":375206000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":45754766.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":46037900.0,"LiabilitiesCurrent_0_Q2_USD":46095000.0,"AccountsPayableCurrent_0_Q2_USD":16817000.0,"InterestExpense_2_Q2_USD":3453000.0,"InterestExpense_1_Q2_USD":1902000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":680158000.0,"LongTermDebtNoncurrent_0_Q2_USD":70780000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.25,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q2_pure":0.25,"AdditionalPaidInCapital_0_Q2_USD":1062234000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":49000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":2637000.0,"CommonStockSharesOutstanding_0_Q2_shares":46050250.0,"ResearchAndDevelopmentExpense_1_Q2_USD":32747000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":432478000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":463868000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":26782000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":960000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":15965000.0,"CommonStockParOrStatedValuePerShare_0_Q2_EUR":0.05,"PaymentsToAcquireBusinessesGross_2_Q2_USD":46300000.0,"CommonStockSharesAuthorized_0_Q2_shares":80000000.0,"OperatingIncomeLoss_2_Q2_USD":353550000.0,"OperatingIncomeLoss_1_Q2_USD":398008000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":30899000.0,"InvestmentIncomeInterest_2_Q2_USD":77000.0,"InvestmentIncomeInterest_1_Q2_USD":37000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":500000.0,"DeferredIncomeTaxExpenseBenefit_1_Q2_USD":200000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":784264000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":6792000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":5752000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":5486000.0,"ProfitLoss_2_Q2_USD":357912000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":3247000.0,"StockholdersEquity_0_Q2_USD":633608000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":6191000.0,"OtherIncome_2_Q2_USD":7942000.0,"OtherIncome_1_Q2_USD":7590000.0,"AssetsNoncurrent_0_Q2_USD":90040000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":464322000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-426819000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":64777000.0,"Ticker":"QURE","CIK":"1590560","name":"UNIQURE N.V.","OfficialName":"uniQure N.V. Ordinary Shares","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"814390930.0","Country":"Netherlands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210726"}]